!!Edith Olah - Selected publications
\\
Selected from 137 publications (citations: 4050/3074; Hirsch-index: 37; cumulative impact factor: 407,594)\\
\\
ALL PUBLICATIONS AVAILABLE: https://vm.mtmt.hu//search/slist.php?lang=0&AuthorID=1169389\\
\\
1.  Kovács ME, Papp J, Szentirmay Z, Otto Sz, OLAH E:\\
     Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome\\
     HUM MUTAT 30(2):197-203, 2009\\
     IF: 6.887\\
     Cit: 43\\
\\
2.  Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, Schackert HK, Steinke V, Holinski-Feder E, Morak M, Kloor M, Büttner R, Verwiel ET, van Krieken JH, Nagtegaal ID, Goossens M, van der Post RS, Niessen RC, Sijmons RH, Kluijt I, Hogervorst FB, Leter EM, Gille JJ, Aalfs CM, Redeker EJ, Hes FJ, Tops CM, van Nesselrooij BP, van Gijn ME, García EB, Eccles DM, Bunyan DJ, Syngal S, Stoffel EM, Culver JO, Palomares MR, Graham T, Velsher L, Papp J, OLAH E, Chan TL, Leung SY, van Kessel AG, Kiemeney LA, Hoogerbrugge N, Ligtenberg MJ:\\
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study\\
LANCET ONCOLOGY 12(1):49-55, 2011 Jan (Epub 2010 Dec 8.)\\
IF: 17.764\\
Cit: 10\\
\\
3.  Papp J, Kovacs ME, Solyom S, Kasler M, Borresen-Dale AL, OLAH E:\\
High prevalence of germline STK11 mutations in Hungarian Peutz-Jeghers Syndrome patients\\
BMC MED GENET 11:169, 2010 (Epub 2010 Nov 30.)\\
IF: 2.439\\
Cit: 4\\
\\
4.  Orbán TI, OLAH E:\\
Emerging roles of BRCA1 alternative splicing (invited review)\\
J CLIN PATHOL: MOL PATHOL 56:191-197, 2003\\
IF: 1.263\\
Cit: 47\\
\\
5. Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, OLAH E, Anton-Culver H, Warner E, Lubinski J, Gronwald V, Gorski B, Tulinius H, Thorlacius S, Eerola Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF:\\
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history, a combined analysis of 22 studies\\
AM J HUM GENET 72(5):1117-1130, 2003\\
IF: 11.602\\
Cit: 809\\
\\
6.  Orbán TI, OLAH E:\\
Purifying selection on silent sites – a constraint from splicing regulation?\\
TRENDS GENET 17:252-253, 2001\\
IF: 12.417\\
Cit: 27\\
\\
7.  Csókay B, Udvarhelyi N, Sulyok Z, Besznyák I, Ramus S, Ponder B, OLAH E:\\
High frequency of germline BRCA2 mutations among Hungarian male breast cancer patients without family history\\
CANCER RES 59(5):995-998, 1999\\
IF: 8.614\\
Cit: 41\\
\\
8.  Ramus S, Járai-Köte Zs, Friedman V, van der Looij M, Gayther SA, Csókay B, Ponder BAJ, OLAH E:\\
Analysis of BRCA1 and BRCA2 mutations in Hungarian breast and/or ovarian cancer families\\
AM J HUM GENET 60:1242-1246, 1997\\
IF: 10.244 \\
Cit: 45\\
\\
9.  Ramus S, Friedman LS, Gayther SA, Ponder BAJ, Bobrow LG, van der Looij M, Papp J, OLAH E:\\
A breast/ovarian cancer patient with germline mutations in both the BRCA1 and BRCA2\\
NAT GENET 15:14-15, 1997\\
IF: 38.854\\
     Cit: 45\\
\\
10. OLAH E, Natsumeda Y, Ikegami T, Köte Zs, Horányi M, Szelényi J, Paulik E, Kremmer T, Hollán SR, Sugár J, Weber G:\\
Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells\\
PROC NATL ACAD SCI USA 85:6533 6537, 1988\\
IF: 10.032\\
Cit: 137\\
\\
Scientific metrics for above 10 publications:\\
Cumulative impact factor: 120.116\\
Citations: 1208